
Saikosaponin A
CAS No. 20736-09-8
Saikosaponin A( Saikosaponin A )
Catalog No. M13225 CAS No. 20736-09-8
Extracted from Bupleurum,scorzonerifolium;Suitability:Water,dilute alcohol,especially the hot water,hot alcohol,butanol and pentanol;Store the product in sealed,cool and dry condition
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 65 | In Stock |
![]() ![]() |
10MG | 113 | In Stock |
![]() ![]() |
25MG | 222 | In Stock |
![]() ![]() |
50MG | 368 | In Stock |
![]() ![]() |
100MG | 536 | In Stock |
![]() ![]() |
200MG | Get Quote | In Stock |
![]() ![]() |
500MG | Get Quote | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product NameSaikosaponin A
-
NoteResearch use only, not for human use.
-
Brief DescriptionExtracted from Bupleurum,scorzonerifolium;Suitability:Water,dilute alcohol,especially the hot water,hot alcohol,butanol and pentanol;Store the product in sealed,cool and dry condition
-
DescriptionExtracted from Bupleurum,scorzonerifolium;Suitability:Water,dilute alcohol,especially the hot water,hot alcohol,butanol and pentanol;Store the product in sealed,cool and dry condition.
-
In VitroWestern Blot Analysis Cell Line:Human osteoarthritis chondrocytes Concentration:5, 10, 15 μM Incubation Time:24 h Result:Inhibited the levels of phosphorylation of NF-κB p65 and IκBα induced byIL-1β.Up-regulated the expression of LXRα in a dose-dependent manner.
-
In VivoAnimal Model:5-FU (HY-90006)-induced mucositis in BALB/c mice modle Dosage:1, 5, 10?mg/kg/day, 7 d Administration:injected intraperitoneally (i.p)Result:Reduced villus blunting, crypt cells apoptosis, and inflammatory cell infiltration.Decreased concentration of GSH, GST, Catalase, and SOD in intestinal tissue.
-
SynonymsSaikosaponin A
-
PathwayApoptosis
-
TargetNF-κB
-
RecptorNF-κB
-
Research AreaOther Indications
-
Indication——
Chemical Information
-
CAS Number20736-09-8
-
Formula Weight780.99
-
Molecular FormulaC42H68O13
-
Purity>98% (HPLC)
-
SolubilityDMSO: 10 mM
-
SMILESO[C@H]([C@H]([C@@H]([C@@H](C)O1)O)O[C@H]2[C@@H]([C@H]([C@@H]([C@@H](CO)O2)O)O)O)[C@@H]1OC3CC[C@]4(C)[C@@]5([H])C=C[C@]67[C@]8([H])CC(C)(C)CC[C@@](CO7)8[C@H](O)C[C@](C)6[C@@](C)5CC[C@]([H])4[C@]3(C)CO
-
Chemical Name(2S,3R,4S,5S,6R)-2-(((2R,3R,4S,5R,6R)-3,5-dihydroxy-2-(((4R,4aR,6aR,6bS,8R,8aS,12aR,12bS,14aR,14bS)-8-hydroxy-4-(hydroxymethyl)-4,6a,6b,11,11,14b-hexamethyl-2,3,4,4a,5,6,6a,6b,7,8,10,11,12,12a,14a,14b-hexadecahydro-1H,9H-12b,8a-(epoxymethano)picen-3-yl)oxy)-6-methyltetrahydro-2H-pyran-4-yl)oxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Zhao H, et al. Exp Ther Med. 2015 Aug;10(2):823-827.
molnova catalog



related products
-
Helenalin
Helenalin (NSC 85236) is a sesquiterpene lactone that covalently targets Cys38 on p65 transcription factor in the canonical NF-κB signaling pathway.
-
Ethyl caffeate
Ethyl caffeate is a potent chemopreventive compound against skin carcinogenesis caused by solar UV exposure.
-
DRI-C21045
Dri-c21045 showed concentration-dependent inhibition of NF-kB activation and all CD40L induced by B cell proliferation with IC50 of 17.1 μM and 4.5 μM.